ROIVANT SCIENCES
Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates. Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. Roivant does this by building Vants - nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying the technology. In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines.
ROIVANT SCIENCES
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Product Research
Founded:
2014-05-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.roivant.com
Total Employee:
501+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.09 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag Nginx Amazon
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-26 | Silicon Therapeutics | Silicon Therapeutics acquired by Roivant Sciences | 450 M USD |
Investors List
Eventide
Eventide investment in Post-IPO Equity - Roivant Sciences
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Post-IPO Equity - Roivant Sciences
Viking Global Investors
Viking Global Investors investment in Post-IPO Equity - Roivant Sciences
RTW Investments LLC
RTW Investments LLC investment in Post-IPO Equity - Roivant Sciences
Patient Square Capital
Patient Square Capital investment in Post-IPO Equity - Roivant Sciences
Palantir Technologies
Palantir Technologies investment in Post-IPO Equity - Roivant Sciences
Dainippon Sumitomo Pharma
Dainippon Sumitomo Pharma investment in Post-IPO Equity - Roivant Sciences
Suvretta Capital Management
Suvretta Capital Management investment in Post-IPO Equity - Roivant Sciences
SoftBank Capital
SoftBank Capital investment in Post-IPO Equity - Roivant Sciences
Novaquest Capital Management
Novaquest Capital Management investment in Private Equity Round - Roivant Sciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-11-03 | Medallion | Roivant Sciences investment in Series B - Medallion | 30 M USD |
| 2021-11-01 | gen-t | Roivant Sciences investment in Pre Seed Round - gen-t | 2 M USD |
| 2021-08-02 | Immunovant | Roivant Sciences investment in Post-IPO Equity - Immunovant | 200 M USD |
| 2020-10-08 | Datavant | Roivant Sciences investment in Series B - Datavant | 40 M USD |
| 2018-04-30 | Datavant | Roivant Sciences investment in Venture Round - Datavant | 40.5 M USD |
| 2017-10-02 | Arbutus Biopharma | Roivant Sciences investment in Post-IPO Equity - Arbutus Biopharma | 116.4 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-02 | Roivant Appoints Chief Development Officer and Announces Multiple Collaborations in Targeted Protein Degradation |
Official Site Inspections
http://www.roivant.com Semrush global rank: 836.93 K Semrush visits lastest month: 45.72 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Roivant Sciences"
Company Overview | Roivant
We develop transformative medicines and technologies by building agile, focused companies called Vants. Roivant was founded in 2014 with the aim to improve the lives of patients by …See details»
Roivant
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to …See details»
Leadership | Roivant - Roivant Sciences
Roivant empowers a global team of innovators from within and beyond the biopharmaceutical industry. We tackle the most pressing challenges in healthcare today. Matt Gline serves as …See details»
Roivant Sciences - Wikipedia
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of BostonSee details»
Roivant Social Ventures
Roivant Social Ventures (RSV) is a social impact organization that invests in health technologies and new therapeutics that lead to systemic improvements to health equity. We invest in new technologies, incubate innovative companies, …See details»
Roivant Corporate Overview
Pipeline Expansion Enabled By Roivant’s Track Record and Balance Sheet • 10-Year track record of finding, securing, and developing high-conviction promising drug candidates • Creative deal …See details»
Roivant Sciences - LinkedIn
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology...See details»
Roivant Sciences - Crunchbase Company Profile
Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates. Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to …See details»
Our Companies | Roivant
View our broad and differentiated pipeline of investigational drugs. Join the team changing the future of healthcare. A career at Roivant is filled with remarkable growth opportunities for those …See details»
Roivant Sciences: Reinventing what a large pharma …
May 7, 2019 · Roivant’s business model involves building nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology to drive greater efficiency …See details»
【Joint press release】Sumitomo Dainippon Pharma and Roivant …
Oct 31, 2019 · Roivant today is comprised of a central technology-enabled platform and 20 Vants with over 45 investigational medicines in clinical and preclinical development and multiple …See details»
Investor Relations | Roivant Sciences Ltd.
Nov 12, 2024 · The Investor Relations website contains information about Roivant Sciences Ltd.'s business for stockholders, potential investors, and financial analysts.See details»
This Pharma Company Stays Innovative by Doing Two Things
Mar 14, 2017 · But Roivant Sciences, a biopharmaceuticals company, bucked the trend by realigning incentives for employees and systematically introducing outside talent and …See details»
Sumitomo, Roivant close $3 billion deal, forming Sumitovant
Dec 31, 2019 · A new international biotech – Sumitovant Biopharma – has been created after Sumitomo Dainippon’s strategic alliance with Roivant Sciences came to fruition as 2019 drew …See details»
Careers | Roivant
We are a team of dedicated scientists, development experts, investors, entrepreneurs, and engineers focused on reinventing the way our industry discovers, develops, and delivers …See details»
Sumitomo Dainippon Pharma and Roivant Sciences Sign a …
Oct 31, 2019 · Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) announced today that it has …See details»
Sumitomo Dainippon Pharma Announces Acquisition of Rights for …
May 7, 2021 · Roivant does this by building Vants - nimble, entrepreneurial biotech and healthcare companies with a unique approach to sourcing talent, aligning incentives, and …See details»
Corporate Responsibility | Roivant
Roivant made Fast Company’s 2024 list of the 100 Best Workplaces for Innovators as well as a spot on the 2024 Biotech list. Our human capital objectives include sourcing, recruiting, …See details»
roivant.com Reviews: Is this site a scam or legit?
Roivant.com is an authentic, safe website, given all the risk factors and data numbers analyzed in this in-depth review. Share your experience in the comments. Domain Blacklisting Status. This …See details»
Pipeline | Roivant
We have a broad and differentiated pipeline of investigational drugs across our family of companies. We have run numerous large successful international Phase 3 clinical trials. Our …See details»